Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
Safety of Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection in Patients With Solid Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
This NA trial investigates C. Difficile Infection and Cancer and is currently completed. Memorial Sloan Kettering Cancer Center leads this study, which shows 18 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
18 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Sep 2024 — May 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2023 — Mar 2024 [monthly]
Active Not Recruiting NA
▶ Show 13 earlier versions
-
Nov 2022 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Nov 2022 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Feb 2020 [monthly]
Recruiting NA
-
May 2019 — Jul 2019 [monthly]
Recruiting NA
-
Mar 2019 — May 2019 [monthly]
Recruiting NA
-
Jul 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .